Eric Van Cutsem, MD, PhD of University of Leuven gives an overview of his second presentation, which focused on the role of novel agents in colorectal cancer patients. This was recorded at the 2017 Great Debates and Updates in GI Malignancies in New York, NY.
Role of Novel Agents for Patients with Chemorefractory Colorectal Cancer
